Optimal and responsible use of antibiotics

Current Opinion in Critical Care
Pieter Depuydt, Jan J De Waele

Abstract

In this review, we focus on the dual face of antibiotic therapy in the critically ill that must harmonize the need for early, appropriate and adequate antibiotic therapy in the individual-infected patient with the obligation to limit antibiotic selection pressure as much as possible to preserve its future potential. Recent articles have highlighted and detailed the various aspects, which determine antibiotic efficacy, and have identified adjunctive treatments, such as source control, which impact outcome. In addition, settings and indications where antibiotics do not improve outcome and may cause harm have been identified. Reconciling antibiotic efficacy with the limitations of their use is feasible but requires a dedicated and sustained effort throughout the whole process of clinical decision-making, from initial suspicion of sepsis to its definitive treatment.

References

Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rodger D MacArthurWilliam Barchuk
Jun 3, 2010·Langenbeck's Archives of Surgery·Jan J De Waele
Aug 25, 2010·Antimicrobial Agents and Chemotherapy·Mical PaulLeonard Leibovici
Jan 25, 2011·The Lancet Infectious Diseases·Daniel H KettUNKNOWN Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators
Dec 25, 2012·Antimicrobial Agents and Chemotherapy·Dana R BowersVincent H Tam
Jul 28, 2013·Nature·Maryn McKenna
Nov 26, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James D ChalmersSantiago Ewig
Jan 17, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jason A RobertsUNKNOWN DALI Study
Mar 5, 2014·Critical Care : the Official Journal of the Critical Care Forum·Frank BloosUNKNOWN MEDUSA Study Group
May 9, 2014·Intensive Care Medicine·Matteo BassettiMario Tumbarello
Jun 28, 2014·The Journal of Antimicrobial Chemotherapy·L E López-CortésUNKNOWN GEIH/REIPI-Ab2010 Group
Jul 6, 2014·Intensive Care Medicine·Dimitrios K MatthaiouGeorge Dimopoulos
Nov 29, 2014·BMC Infectious Diseases·Jan De Waele, Liesbet De Bus
Sep 9, 2015·Critical Care : the Official Journal of the Critical Care Forum·Peter M C Klein KlouwenbergTom van der Poll
Dec 26, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alexis TabahJan J De Waele
Jan 10, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naomi J GadsbyKate E Templeton
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Mervyn SingerDerek C Angus
Mar 18, 2016·Intensive Care Medicine·P MontraversJ De Waele
Jul 13, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James D ChalmersMarcos I Restrepo
Jul 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andre C KalilJan L Brozek
Aug 1, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S EmonetJ Schrenzel
Jan 20, 2017·Intensive Care Medicine·Andrew RhodesR Phillip Dellinger
Mar 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David S Y OngUNKNOWN MARS consortium
Apr 15, 2017·Intensive Care Medicine·T TängdénUNKNOWN Infection Section for the European Society of Intensive Care Medicine, the Pharmacokinetics and Pharmacodynamics Study Group
May 23, 2017·The New England Journal of Medicine·Christopher W SeymourMitchell M Levy
May 26, 2017·Journal of Clinical Microbiology·Thomas R Kozel, Amanda R Burnham-Marusich
Feb 14, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vlad DraganJerome A Leis
Jul 28, 2018·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Stephanie Royer, Hallie C Prescott
Oct 1, 2018·Critical Care : the Official Journal of the Critical Care Forum·Liesbet De BusPieter Depuydt
Oct 13, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean-Ralph ZaharFrançois Barbier
Nov 2, 2018·Current Opinion in Infectious Diseases·Jan J De Waele, Ignacio Martin-Loeches
Oct 23, 2019·The Journal of Applied Laboratory Medicine·Donna M Wolk, J Kristie Johnson

❮ Previous
Next ❯

Citations

Aug 17, 2021·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Yoshitaka HaraOsamu Nishida

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.